RedHill Biopharma (RDHL) Reports Q4 Loss of $0.04/Share
RedHill Biopharma (NASDAQ: RDHL) reported Q4 EPS of ($0.04), versus ($0.05) reported last year.
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
RedHill Biopharma (NASDAQ: RDHL) reported Q4 EPS of ($0.04), versus ($0.05) reported last year.
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.